Advanced search
Publication Cover
Journal of Blood Medicine Volume 12, 2021 - Issue
Submit an article Journal homepage
120
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Possible Role of CD11a in Primary Immune Thrombocytopenia Patients on Immunosuppressive Therapy

Muhamad R Abdel Hameed1 Hematology Unit, Department of Internal Medicine, Assiut University Hospitals, Assiut University, Assiut, Egypt;2 Bone Marrow Transplantation Unit, South Egypt Cancer Institute, Assiut University, Assiut, EgyptCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9084-4079View further author information
ORCID Icon,
Howiada A Nafady1 Hematology Unit, Department of Internal Medicine, Assiut University Hospitals, Assiut University, Assiut, Egypt;2 Bone Marrow Transplantation Unit, South Egypt Cancer Institute, Assiut University, Assiut, EgyptView further author information
,
Mona Ibrahim Mostafa3 Department of Internal Medicine, Assiut General Hospital, Assiut, EgyptView further author information
,
Douaa Sayed4 Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut, EgyptView further author information
&
Ahmad A Obiedallah5 Critical Care Unit, Department of Internal Medicine, Assiut University Hospitals, Assiut University, Assiut, EgyptORCID Iconhttps://orcid.org/0000-0003-2384-003XView further author information
ORCID Icon
Pages 197-205 | Published online: 25 Mar 2021

References

  • McMillan R. Immune-mediated thrombocytopenias focus on chronic immune thrombocytopenic purpura. Semin Hematol. 2007;44:1–2. doi:10.1053/j.seminhematol.2007.11.001
  • Ahn YS, Horstman LL. Idiopathic thrombocytopenic purpura: pathophysiology and management. Int J Hematol. 2002;76(2):123–131. doi:10.1007/BF03165102
  • Kawana M, Ikeda Y. The role of autoreactive T Cells in the pathogenesis of idiopathic thrombocytopenic purpura. Int J Hematol. 2005;81:106–112. doi:10.1532/IJH97.04176
  • Kim SY, Solomon DH. Tumor necrosis factor blockade and the risk of viral infections. Nat Rev Rheumatol. 2010;6(3):165–174. doi:10.1038/nrrheum.2009.279
  • Targownik LE, Bernstein CN. Infectious and malignant complications of TNF inhibitor therapy in IBD. Am J Gastroenterol. 2013;108(12):1835–1842. doi:10.1038/ajg.2013.294
  • McKenzie CG, Guo L, Freedman J, Semple JW. Cellular immune dysfunction in immune thrombocytopenia (ITP). Br J Hematol. 2013;163:10–23. doi:10.1111/bjh.12480
  • Ghislin S, Obino D, Middendorp S, Boggetto N, Alcaide-Loridan C, Deshayes FLFA. 1 and ICAM-1 expression induced during melanomaendothelial cell co-culture favors the transendothelial migration of melanoma cell lines in vitro. BMC Cancer. 2012;12:455. doi:10.1186/1471-2407-12-455
  • Parameswaran N, Suresh R, Bal V, Rath S, George A. Lack ofICAM-1 on APCs during T cell priming leads to poor generation of central memory cells. J Immunol. 2005;175:2201–2211. doi:10.4049/jimmunol.175.4.2201
  • Pribila JT, Quale AC, Mueller KL, Shimizu Y. Integrins and T cell mediated immunity. Annu Rev Immunol. 2004;22:157–180. doi:10.1146/annurev.immunol.22.012703.104649
  • Bose TO, Colpitts SL, Pham QM, Puddington L, Lefrançois L. CD11a is essential for normal development of hematopoietic intermediates. J Immunol. 2014;193:2863–2872. doi:10.4049/jimmunol.1301820
  • Neunert C, Lim W, Crowther M. The American Society of Hematology 2011 evidence-based practice, guidelines for immune thrombocytopenia. Blood. 2011;117:4190–4207. doi:10.1182/blood-2010-08-302984
  • Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;10(23):3829–3866. doi:10.1182/bloodadvances.2019000966
  • Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386–2393. doi:10.1182/blood-2008-07-162503.
  • Abbasi SY, Milhem M, Zaru L. A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura. Ann Hematol. 2008;87(6):459–462. doi:10.1007/s00277-008-0448-1
  • Grimaldi-Bensouda L, Nordon C, Michel M, et al. Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome. Haematologica. 2016;101(9):1039–1045. doi:10.3324/haematol.2016.146373.
  • Rosenblum MD, Remedios KA, Abbas AK. Mechanisms of human autoimmunity. J Clin Invest. 2015;125(6):2228–2233.
  • Carrasco YR, Fleire SJ, Cameron T, Dustin ML, Batista FD. LFA-1/ICAM-1 interaction lowers the threshold of B cell activation by facilitating B cell adhesion and synapse formation. Immunity. 2004;20:589–599. doi:10.1016/S1074-7613(04)00105-0
  • Sela U, Mauermann N, Hershkoviz R, et al. The inhibition of autoreactive T cell functions by a peptide based on the CDR1 of an anti-DNA autoantibody is via TGF-beta mediated suppression of LFA-1 and CD44 expression and function. J Immunol. 2005;175:7255–7263. doi:10.4049/jimmunol.175.11.7255
  • Liu YX, Zhang F, Yao QM, Yuan T, Xu J, Zhu XJ. Expression of CD11a in lymphocyte subpopulation in immune thrombocytopenia. Int J Clin Exp Pathol. 2015;8(12):15642–15651.
  • Provan D, D M A, J B B, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. J Blood Adv. 2019;3:3780–3817.
  • Stephen C, Pflugfelder MS, Steven Z, Amir SLFA. 1/ICAM-1 interaction as a therapeutic target in dry eye disease. J Ocular Pharmacol Ther. 2017;33(1). doi:10.1089/jop.2016.0105

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.